Fenamole

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 592406

CAS#: 5467-78-7

Description: Fenamole is a biochemical.


Chemical Structure

img
Fenamole
CAS# 5467-78-7

Theoretical Analysis

MedKoo Cat#: 592406
Name: Fenamole
CAS#: 5467-78-7
Chemical Formula: C7H7N5
Exact Mass: 161.07
Molecular Weight: 161.170
Elemental Analysis: C, 52.17; H, 4.38; N, 43.45

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: NSC 25413; NSC-25413; NSC25413; Fenamole

IUPAC/Chemical Name: 1H-Tetrazol-5-amine, 1-phenyl-

InChi Key: ULIDRMKBVYYVIQ-UHFFFAOYSA-N

InChi Code: InChI=1S/C7H7N5/c8-7-9-10-11-12(7)6-4-2-1-3-5-6/h1-5H,(H2,8,9,11)

SMILES Code: NC1=NN=NN1C2=CC=CC=C2

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.03.00

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 161.17 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Alfano A, Corsuto L, Finamore R, Savarese M, Ferrara F, Falco S, Santabarbara G, De Rosa M, Schiraldi C. Valorization of Olive Mill Wastewater by Membrane Processes to Recover Natural Antioxidant Compounds for Cosmeceutical and Nutraceutical Applications or Functional Foods. Antioxidants (Basel). 2018 May 23;7(6). pii: E72. doi: 10.3390/antiox7060072. PubMed PMID: 29882862; PubMed Central PMCID: PMC6025363.

2: Finamore A, Ambra R, Nobili F, Garaguso I, Raguzzini A, Serafini M. Redox Role of Lactobacillus casei Shirota Against the Cellular Damage Induced by 2,2'-Azobis (2-Amidinopropane) Dihydrochloride-Induced Oxidative and Inflammatory Stress in Enterocytes-Like Epithelial Cells. Front Immunol. 2018 May 24;9:1131. doi: 10.3389/fimmu.2018.01131. eCollection 2018. PubMed PMID: 29881384; PubMed Central PMCID: PMC5976738.

3: Finamore P, Pedone C, Scarlata S, Di Paolo A, Grasso S, Santonico M, Pennazza G, Antonelli Incalzi R. Validation of exhaled volatile organic compounds analysis using electronic nose as index of COPD severity. Int J Chron Obstruct Pulmon Dis. 2018 May 1;13:1441-1448. doi: 10.2147/COPD.S159684. eCollection 2018. PubMed PMID: 29750030; PubMed Central PMCID: PMC5936003.

4: Scarlata S, Finamore P, Santangelo S, Giannunzio G, Pennazza G, Grasso S, Santonico M, Incalzi RA. Cluster analysis on breath print of newly diagnosed COPD patients: effects of therapy. J Breath Res. 2018 Jun 8;12(3):036022. doi: 10.1088/1752-7163/aac273. PubMed PMID: 29724960.

5: Finamore P, Scarlata S, Laudisio A, Galdi F, Pipita ME, Chiarella I, Giua R, Cortese L, Rivera C, Antonelli Incalzi R. Occurrence of nocturia is not mediated by nocturnal hypoxia length and severity in patients with sleep-disordered breathing. Sleep Med. 2018 May;45:69-73. doi: 10.1016/j.sleep.2018.01.009. Epub 2018 Feb 7. PubMed PMID: 29680431.

6: Finamore P, Pedone C, Lelli D, Costanzo L, Bartoli IR, De Vincentis A, Grasso S, Parente FR, Pennazza G, Santonico M, Incalzi RA. Analysis of volatile organic compounds: an innovative approach to heart failure characterization in older patients. J Breath Res. 2018 Feb 6;12(2):026007. doi: 10.1088/1752-7163/aa8cd4. PubMed PMID: 29408802.

7: Roselli M, Devirgiliis C, Zinno P, Guantario B, Finamore A, Rami R, Perozzi G. Impact of supplementation with a food-derived microbial community on obesity-associated inflammation and gut microbiota composition. Genes Nutr. 2017 Oct 4;12:25. doi: 10.1186/s12263-017-0583-1. eCollection 2017. PubMed PMID: 29043005; PubMed Central PMCID: PMC5628415.

8: Pilkinton ML, Levine GC, Bennett L, Winkler HA, Shalom DF, Finamore PS. Comparison of strength of sacrocolpopexy mesh attachment using barbed and nonbarbed sutures. Int Urogynecol J. 2018 Jan;29(1):153-159. doi: 10.1007/s00192-017-3451-z. Epub 2017 Oct 4. PubMed PMID: 28980021.

9: Peissig P, Schwei KM, Kadolph C, Finamore J, Cancel E, McCarty CA, Okorie A, Thomas KL, Allen Pacheco J, Pathak J, Ellis SB, Denny JC, Rasmussen LV, Tromp G, Williams MS, Vrabec TR, Brilliant MH. Prototype Development: Context-Driven Dynamic XML Ophthalmologic Data Capture Application. JMIR Med Inform. 2017 Sep 13;5(3):e27. doi: 10.2196/medinform.7465. PubMed PMID: 28903894; PubMed Central PMCID: PMC5617903.

10: Scarlata S, Finamore P, Giannunzio G, Santangelo S, Antonelli Incalzi R. Chest ultrasonography in health surveillance of asbestos related pleural disease. Lung Cancer. 2017 Sep;111:139-142. doi: 10.1016/j.lungcan.2017.07.019. Epub 2017 Jul 22. PubMed PMID: 28838385.

11: Palmeri R, Restuccia C, Monteleone JI, Sperlinga E, Siracusa L, Serafini M, Finamore A, Spagna G. Bioactivity Improvement of Olea europaea Leaf Extract Biotransformed by Wickerhamomyces anomalus Enzymes. Plant Foods Hum Nutr. 2017 Jun;72(2):211-218. doi: 10.1007/s11130-017-0612-7. PubMed PMID: 28503711.

12: Cimini D, Iacono ID, Carlino E, Finamore R, Restaino OF, Diana P, Bedini E, Schiraldi C. Engineering S. equi subsp. zooepidemicus towards concurrent production of hyaluronic acid and chondroitin biopolymers of biomedical interest. AMB Express. 2017 Dec;7(1):61. doi: 10.1186/s13568-017-0364-7. Epub 2017 Mar 14. PubMed PMID: 28293868; PubMed Central PMCID: PMC5350083.

13: De Marino S, Carino A, Masullo D, Finamore C, Marchianò S, Cipriani S, Di Leva FS, Catalanotti B, Novellino E, Limongelli V, Fiorucci S, Zampella A. Hyodeoxycholic acid derivatives as liver X receptor α and G-protein-coupled bile acid receptor agonists. Sci Rep. 2017 Feb 24;7:43290. doi: 10.1038/srep43290. PubMed PMID: 28233865; PubMed Central PMCID: PMC5324103.

14: Finamore A, Palmery M, Bensehaila S, Peluso I. Antioxidant, Immunomodulating, and Microbial-Modulating Activities of the Sustainable and Ecofriendly Spirulina. Oxid Med Cell Longev. 2017;2017:3247528. doi: 10.1155/2017/3247528. Epub 2017 Jan 15. Review. PubMed PMID: 28182098; PubMed Central PMCID: PMC5274660.

15: Restaino OF, Finamore R, Diana P, Marseglia M, Vitiello M, Casillo A, Bedini E, Parrilli M, Corsaro MM, Trifuoggi M, De Rosa M, Schiraldi C. A multi-analytical approach to better assess the keratan sulfate contamination in animal origin chondroitin sulfate. Anal Chim Acta. 2017 Mar 15;958:59-70. doi: 10.1016/j.aca.2016.12.005. Epub 2016 Dec 22. PubMed PMID: 28110685.

16: Cimini D, Corte KD, Finamore R, Andreozzi L, Stellavato A, Pirozzi AV, Ferrara F, Formisano R, De Rosa M, Chino M, Lista L, Lombardi A, Pavone V, Schiraldi C. Production of human pro-relaxin H2 in the yeast Pichia pastoris. BMC Biotechnol. 2017 Jan 14;17(1):4. doi: 10.1186/s12896-016-0319-0. PubMed PMID: 28088197; PubMed Central PMCID: PMC5237503.

17: Kissane LM, Calixte R, Grigorescu B, Finamore P, Vintzileos A. Impact of Obesity on Robotic-Assisted Sacrocolpopexy. J Minim Invasive Gynecol. 2017 Jan 1;24(1):36-40. doi: 10.1016/j.jmig.2016.10.012. Epub 2016 Nov 1. PubMed PMID: 27810437.

18: Cimini D, Argenzio O, D'Ambrosio S, Lama L, Finore I, Finamore R, Pepe O, Faraco V, Schiraldi C. Production of succinic acid from Basfia succiniciproducens up to the pilot scale from Arundo donax hydrolysate. Bioresour Technol. 2016 Dec;222:355-360. doi: 10.1016/j.biortech.2016.10.004. Epub 2016 Oct 3. PubMed PMID: 27741473.

19: Roselli M, Finamore A, Hynönen U, Palva A, Mengheri E. Differential protection by cell wall components of Lactobacillus amylovorus DSM 16698(T)against alterations of membrane barrier and NF-kB activation induced by enterotoxigenic F4(+) Escherichia coli on intestinal cells. BMC Microbiol. 2016 Sep 29;16(1):226. PubMed PMID: 27688074; PubMed Central PMCID: PMC5041403.

20: Williams KS, Shalom DF, Hill JR, Winkler HA, Finamore PS. Robotic-Assisted Removal of Transvaginal Mesh, a Minimally-Invasive Approach. J Minim Invasive Gynecol. 2015 Nov-Dec;22(6S):S154. doi: 10.1016/j.jmig.2015.08.577. Epub 2015 Oct 15. PubMed PMID: 27678876.